Search

Author/Creator Gridelli, C

1. 609TiPIntermittent or continuous panitumumab (PAN) plus FOLFIRI for first-line treatment of patients (pts) with RAS/BRAF wild-type (WT) metastatic colorectal cancer (mCRC): A randomized phase II trial (IMPROVE). (23rd October 2018)

Authors:
De Stefano, A; Nasti, G; Febbraro, A; Rosati, G; Giuliani, F; Santini, D; Aprile, G; Scartozzi, M; Silvestris, F; Luppi, G; Lolli, I; Mastroianni, C; Leo, S; Montesarchio, V; Gridelli, C; Pozzo, C; Sperti, E; Giannarelli, D; Budillon, A; Avallone, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. LBA64nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study. (23rd October 2018)

Authors:
Spigel, D R; Jotte, R M; Ponce Aix, S; Gressot, L; Morgensztern, D; McCleod, M; Socinski, M A; Daniel, D; Juan-Vidal, O; Kim, E S; West, H J; Chen, T; Bhore, R; Ong, T J; Gridelli, C; Thomas, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗